https://scholars.lib.ntu.edu.tw/handle/123456789/589284
標題: | Survey of amphotericin B susceptibility of Candida clinical isolates determined by Etest | 作者: | Chiu Y.-S. SHAN-CHWEN CHANG PO-REN HSUEH Wang J.-L. HSIN-YUN SUN YEE-CHUN CHEN |
公開日期: | 2006 | 卷: | 39 | 期: | 4 | 起(迄)頁: | 335-341 | 來源出版物: | Journal of Microbiology, Immunology and Infection | 摘要: | Background and Purpose: The minimal inhibitory concentrations (MICs) of amphotericin B (AmB) determined by the National Committee for Clinical Laboratory Standards (NCCLS; NCCLS document M27-A) broth dilution method are in a relatively narrow ranges and this may lead to underestimation of the AmB-resistant rate in clinical isolates. We evaluated in vitro susceptibility of clinical isolates of Candida spp. to AmB using Etest and determined the distribution of AmB MICs in different species. Methods: We used the Etest (AB Biodisk, Solna, Sweden) to evaluate the MICs of Candida isolates randomly collected during 2001-2003 in a teaching hospital. Results: Of the 572 isolates evaluated, Candida albicans (50.7%) was the most common species, followed by Candida tropicalis (23.9%), Candida parapsilosis (13.1%), Candida glabrata (9.4%), Candida krusei (1.9%), and Candida guilliermondii (0.9%). The majority of isolates were from blood (85%). The minimal concentrations of AmB required to inhibit 50%/90% of the isolates (MIC50.MIC90) were 0.19/0.38 μg/mL for C. krusei, 0.125/0.38 μg/mL for C. glabrata, 0.094/0.25 μg/mL for C. tropicalis, 0.032/0.19 μg/mL for C. albicans, 0.016/0.125 μg/mL for C. parapsilosis, and 0.023/0.032 μg/mL for C. guilliermondii. Only 1 blood isolate of C. glabrata was resistant to AmB (MIC ?1 μg/mL) [0.17%]. 18.2% of isolates were less susceptible to AmB (MIC ?0.19 μg/mL) with the highest rates for C. krusei (63.6%), followed by C. glabrata (37.0%), C. tropicalis (29.9%), C. albicans (11.0%), C. parapsilosis (5.3%), and C. guilliermondii (0%). More isolates collected from patients with hematologic malignancy were less susceptible to AmB than those collected from those with other diseases (30.5% vs 15.4%, p<0.05). Conclusion: This study demonstrated that AmB resistance remains rare at this hospital in Candida clinical isolates despite increasing use of this agent during the past 4 decades. ? 2006 Journal of Microbiology, Immunology and Infection. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750596120&partnerID=40&md5=e0ca0134fc0580a336d7992e9861496f https://scholars.lib.ntu.edu.tw/handle/123456789/589284 |
ISSN: | 1684-1182 | SDG/關鍵字: | amphotericin B; article; blood sampling; Candida; Candida albicans; Candida glabrata; Candida guilliermondii; Candida krusei; Candida parapsilosis; Candida tropicalis; controlled study; drug sensitivity; hematologic malignancy; human; in vitro study; major clinical study; minimum inhibitory concentration; teaching hospital; Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。